T2 Biosystems Inc (TTOO) Stock: What Does the Chart Say Friday?

Overall market sentiment has been down on T2 Biosystems Inc (TTOO) stock lately. TTOO receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

T2 Biosystems Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on TTOO!

See Full TTOO Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With TTOO Stock Today?

T2 Biosystems Inc (TTOO) stock is trading at $2.89 as of 9:31 AM on Friday, Mar 22, a drop of -$0.13, or -4.3% from the previous closing price of $3.02. The stock has traded between $2.82 and $3.04 so far today. Volume today is light. So far 30,130 shares have traded compared to average volume of 370,567 shares.

More About T2 Biosystems Inc

T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease. Click Here to get the full Stock Report for T2 Biosystems Inc stock.